Crossmark

Guideline-directed antihypertensive medication use among young adult participants with uncontrolled hypertension at enrollment in the MyHEART study

Published Online: 2024-11-13

Authors

Knutson Sinaise, Megan R.

Zaborek, Jennifer

Kim, KyungMann

Lauver, Diane R.

McBride, Patrick

Pearson, Jane

Licon, Allexa

Joseph, Anupama

Johnson, Heather M.

Hoppe, Kara K.
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (R01HL132148, R01HL132148, R01HL132148, R01HL132148, R01HL132148, R01HL132148)
License Information

Text and Data Mining valid from 2024-11-13

Version of Record valid from 2024-11-13
More Information

Article History

Received: 11 December 2023

Accepted: 30 October 2024

First Online: 13 November 2024

Declarations

:

: Participants gave their voluntary, informed consent to participate in the MyHEART Trial. They were reimbursed up to $150 for their participation. This study followed the Declaration of Helsinki principles and Good Clinical Practice Guidelines. This study was approved by the University of Wisconsin Institutional Review Board.

: Not applicable.

: The authors declare no competing interests.

Document is current